Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Payables: 2009-2025

Historic Payables for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $45.5 million.

  • Nutex Health's Payables rose 34060.94% to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.5 million, marking a year-over-year increase of 34060.94%. This contributed to the annual value of $9.6 million for FY2024, which is 4913.01% down from last year.
  • Latest data reveals that Nutex Health reported Payables of $45.5 million as of Q3 2025, which was up 34060.94% from $28.1 million recorded in Q2 2025.
  • Over the past 5 years, Nutex Health's Payables peaked at $45.5 million during Q3 2025, and registered a low of $4.2 million during Q1 2022.
  • Its 5-year average for Payables is $16.3 million, with a median of $16.7 million in 2024.
  • Per our database at Business Quant, Nutex Health's Payables soared by 114835.2% in 2021 and then crashed by 4913.01% in 2024.
  • Quarter analysis of 5 years shows Nutex Health's Payables stood at $14.5 million in 2021, then skyrocketed by 63.31% to $23.6 million in 2022, then dropped by 19.97% to $18.9 million in 2023, then crashed by 49.13% to $9.6 million in 2024, then soared by 373.01% to $45.5 million in 2025.
  • Its Payables stands at $45.5 million for Q3 2025, versus $28.1 million for Q2 2025 and $19.8 million for Q1 2025.